Workflow
Nasdaq(NDAQ)
icon
Search documents
Nasdaq and S&P 500 rebound called after Wall Street's worst day in three years
Proactiveinvestors NA· 2025-03-11 12:26
About this content About Oliver Haill Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup ...
Nasdaq Sell-Off: You Won't Believe What Stock Is Near a 52-Week Low
The Motley Fool· 2025-03-11 12:03
One of the biggest names in AI is selling for its cheapest price in a year.You may not have noticed -- it's not getting a lot of attention -- but the last few days, the tech-heavy Nasdaq stock exchange has been in kind of a funk.Since hitting its all-time closing high of 20,056 back on Feb. 19, the tech-heavy stock index has fallen an unlucky 13%, closing Monday at 17,453. Stocks of all stripes have gotten hit, including one market giant whose fall I bet almost nobody saw coming:Microsoft (MSFT -3.34%) is d ...
Nasdaq Sell-Off: 2 Top Stocks to Buy and Hold Forever
The Motley Fool· 2025-03-11 11:45
Fears about a potential recession and a tariff war between the U.S. and its trade partners are causing significant volatility in the stock market. The tech-heavy Nasdaq Composite has taken the brunt of the drop, falling 13.4% since its recent highs in December and 9.5% since the beginning of 2025.While some investors may think running for the hills is the best strategy right now, those with cooler heads have a superb buying opportunity -- if they know where to look. Here's why the recent pullback from Nvidi ...
This Stock Dropped 47% in the Past 4 Weeks and Could Be a No-Brainer Buy During the Nasdaq Correction
The Motley Fool· 2025-03-11 10:04
Financial technology company Upstart (UPST -11.71%) has taken investors on quite a bumpy ride over the past year or so. After falling dramatically in the post-pandemic years, Upstart's stock price more than quadrupled from its 52-week low after three consecutive strong earnings reports.However, it has also been one of the hardest-hit stocks in the recent downturn. As of Monday, Upstart's stock had lost 46.6% of its value since its recent high on Feb. 12 as the broader Nasdaq Composite plummeted from its own ...
Nasdaq Sell-Off: These 3 "Safe Stocks" Finally Look Like Bargains
The Motley Fool· 2025-03-11 10:00
The plunge is punishing some stocks far more than is merited. That spells opportunity for level-headed investors.Panicked yet? It would be a little surprising if you weren't at least a bit. Now down more than 10% from its most recent peak, the Nasdaq Composite (NASDAQINDEX: ^IXIC) is officially in correction territory. Such big tumbles often precede even more weakness, even if that continued selling is only rooted in fear, and the result of a self-fulfilling prophecy.However, the Nasdaq's steep pullback is ...
Nasdaq Correction: The 2 Smartest Stocks to Buy and Hold Forever
The Motley Fool· 2025-03-11 09:31
When you're on an airplane, the pilot or a flight attendant will typically announce over the loudspeaker to "buckle your seatbelt" when the air is turbulent. That could be good advice for investors right now, too.The Nasdaq Composite Index (^IXIC -4.00%) is now squarely in correction territory. But stock market corrections have one key redeeming quality: They provide excellent opportunities to buy great stocks at a discount. Here are my picks for the two smartest stocks to buy during the current Nasdaq corr ...
1 No-Brainer Artificial Intelligence (AI) ETF to Buy With $40 During the Nasdaq Sell-Off
The Motley Fool· 2025-03-11 08:59
Core Viewpoint - The Nasdaq Composite index, heavily influenced by technology companies, has seen significant volatility, presenting potential investment opportunities in AI-focused ETFs as individual stock picking may be riskier [1][2]. Group 1: Market Performance - The Nasdaq Composite index gained 28.6% last year but has recently fallen 13.4% from its record high, entering correction territory [2]. - The iShares Future AI and Tech ETF is down 20.6% from its recent high, with shares available for under $40 [3]. Group 2: ETF Overview - The iShares Future AI and Tech ETF, reconstructed in August 2022, focuses exclusively on AI companies, holding only 50 stocks, which leads to potential volatility [4]. - The ETF's top 10 holdings include major AI players such as Broadcom, Nvidia, and Palantir Technologies, with Broadcom's AI revenue increasing 77% year over year to $4.1 billion [5][6][8]. Group 3: Industry Insights - The AI industry is still developing, with Nvidia's CEO predicting next-generation AI models will require 100 times more computing power, indicating a long-term growth trajectory for AI infrastructure [11]. - Major tech companies like Meta Platforms, Alphabet, Microsoft, and Amazon are projected to spend over $300 billion on hardware in 2025, benefiting companies within the iShares ETF [12][13]. Group 4: Investment Strategy - The iShares ETF has delivered a return of 6.1% since its reconstruction, outperforming the S&P 500's 5.1% gain over the same period, suggesting it could be a valuable addition to a diversified portfolio [10]. - Investing in the iShares ETF allows exposure to a range of high-quality AI stocks, potentially leading to significant long-term returns while mitigating risks associated with individual stock performance [14].
Nasdaq 100: Apple and Nvidia Selloff Sparks AI Concerns – What's Next for US Stocks?
FX Empire· 2025-03-11 08:46
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...
The Top Nasdaq-100 Stock in 2025 Has Nothing to Do With Artificial Intelligence (AI)
The Motley Fool· 2025-03-11 08:20
Group 1: Market Overview - In 2024, technology stocks involved in artificial intelligence (AI) led the Nasdaq-100 index higher, while healthcare stocks struggled due to concerns about Robert F. Kennedy's nomination for Health and Human Services Secretary [1] - In 2025, the technology sector has disappointed investors, while healthcare stocks have led the U.S. market higher, with Gilead Sciences being the best performing member of the Nasdaq-100 index as of March 9, achieving a year-to-date return of 27% [1] Group 2: Company Performance - AppLovin reported a 44% increase in revenue to $1.3 billion in Q4, with non-GAAP net income more than tripling, but the stock has fallen 47% from its high this year due to negative reports from short sellers [3] - Palantir consistently beat Wall Street's expectations with its financial results last year, but the stock has fallen 32% from its high this year due to concerns about insider selling and possible Pentagon budget cuts [4] - Nvidia, the market leader in data center GPUs, has seen its stock fall 25% from its high this year due to concerns about the sustainability of AI infrastructure spending and export restrictions [5] Group 3: Analyst Sentiment - Despite recent declines, Wall Street remains predominantly bullish on AppLovin, Palantir, and Nvidia, with median target prices implying substantial upside for shareholders [6] - AppLovin's median target price of $555 per share implies 132% upside from its current share price of $239, Palantir's median target price of $97 per share implies 22% upside from its current share price of $79, and Nvidia's median target price of $175 per share implies 65% upside from its current share price of $106 [10] Group 4: Gilead Sciences - Gilead Sciences is a pharmaceutical company with a strong presence in the HIV and oncology markets, known for developing the first once-daily tablet for HIV treatment and receiving approval for a pre-exposure prophylaxis (PrEP) HIV medication [7] - Gilead reported Q4 financial results that beat Wall Street expectations, with revenue increasing 6% to $7.6 billion and non-GAAP net income increasing 10% to $1.90 per diluted share [8] - Gilead anticipates regulatory approval of twice-yearly lenacapavir injections for HIV pre-exposure prophylaxis in the U.S. and updates from two phase-3 clinical trials involving Trodelvy, which has been designated as a breakthrough therapy by the FDA [9][12] - Gilead shares trade at a reasonable price, with Wall Street expecting adjusted earnings to increase at 32% annually over the next two years, making the current price-to-earnings (PE) multiple of 25 look fair [13]
Nasdaq Sell-Off: Time to Buy the Dip on Nvidia?
The Motley Fool· 2025-03-11 08:00
Investors haven't had many chances to consider buying shares of the artificial intelligence (AI) leader Nvidia (NVDA -5.07%) on a big dip over the last several years. But now is one of those times. In fact the recent pullback in Nvidia shares is the largest drop from a recent high in the last two years. Shares are down 20% year to date, and 28% off a January high.There are many reasons stocks drop. Company-specific news, investors rotating away from one sector toward others, and general risk angst are a few ...